Annovis Bio, Inc. - ANVS Total Company Value

Brandmark of annovisbio.com (ANVS)

This daily price chart for Annovis Bio, Inc. (ANVS) reflects an enterprise value currently priced at 24.80. The business focuses on developing neuron restoration methods by optimizing intracellular transport. The project targets a massive untapped segment of dementia and tremor therapies. Intellectual property protections preclude pricing wars, leaving risks solely to potential scientific breakthroughs by other laboratories.

Total Company Value: Annovis Bio Corporation (ANVS) for 11/23/2025 - 10/30/2026

Annovis Bio, Inc. - analytical breakdowns and key metrics (ANVS)

- share price and expert price forecast:
Share Price Annovis Bio Inc|ANVS - Consensus Target
- issuer market value details:
Market Value Annovis Bio|ANVS - Total Company Value
- business book valuation details:
Net Assets per Share Annovis Bio|ANVS - Company Book Value|Capitalization to Book Value Ratio annovisbio.com|ANVS - Company Total Assets
- debt level and financial liquidity data:
Debt to Capital Annovis Bio, Inc.|ANVS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital annovisbio.com|ANVS - Company Debts|Debt to Net Assets Ratio Annovis Bio|ANVS - Company Long-Term Debt|Short-Term Debt Annovis Bio|Quick Ratio annovisbio.com
- company profitability and valuation multiples indicators:
ANVS - Company Net Income
Analysis of all company metrics:Annovis Bio Inc
Manufactured product of Annovis Bio, Inc.

When screening assets, an investor evaluates the real value of a business by excluding market capitalization distortions. This metric sums the value of shares and debt, subtracting available cash. For Annovis Bio, Inc. (ANVS), which invests in the joint development of dementia drugs, this reflects the actual cost of acquiring the company. An analysis of market value, accounting for liquidity and liabilities on GURU.Markets, reveals the true dynamics of interest in the firm's biotechnological potential.

Competitors of Annovis Bio, Inc. (ANVS)

BIIB: Business Value|NBIX: Real Price to Acquire Entire Company|RGC: Total Company Value|Axsome Therapeutics (AXSM) - Total Company Value|ACAD - Company Buyout Price|Total Company Value Xenon|Business Value VKTX (Viking Therapeutics Inc)|Enterprise Value SUPN|CPRX - Total Enterprise Value|Denali Therapeutics - Real Price to Acquire Entire Company|Enterprise Value harmonybiosciences.com HRMY|BHVN - Total Company Value|Value Adjusted for Debt and Cash AMLX (Amylyx Pharmaceuticals Inc)|Trevi Pharma (TRVI) - Total Company Value|Total Enterprise Value Praxis Corp (PRAX)|AVXL (Anavex Life Sciences) - Enterprise Value|Enterprise Value ceribell.com|Total Company Value Prothena Biosciences (PRTA)|alector.com - Business Value|Total Company Value Annexon Inc. ANNX|OMER: Business Value|NGNE - Total Company Value|Total Enterprise Value acimmune.com|VYGR (Voyager Therapeutics, Inc.) - Real Price to Acquire Entire Company|NMRA (Neumora) - Total Company Value|SCLX (Scilex Holding Co.) - Enterprise Value|Tevogen Bio Inc. (TVGN) - Company Buyout Price|Total Company Value Alpha Cognition (ACOG)|Company Buyout Price Cognition Therapeutics Inc.|Inhibikase Therapeutics, Inc. - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash SAVA|Assertio Therapeutics - Enterprise Value|COYA: Total Company Value|VTGN: Enterprise Value|OVID - Company Buyout Price|Total Company Value Acumen Pharmaceuticals, Inc.|Total Enterprise Value CervoMed, Inc. CRVO|Real Price to Acquire Entire Company ATHE (Alterity Therapeutics)|CLNN (clene.com) - Value Adjusted for Debt and Cash|Enterprise Value PEPG (PepGen)|Company Buyout Price Jupiter Neurosciences, Inc. (JUNS)|RLMD - Total Company Value|GRCE (Grace Therapeutics, Inc.) - Business Value|AIFF: Enterprise Value|Real Price to Acquire Entire Company Klotho Neurosciences|Real Price to Acquire Entire Company NRSN|revivapharma.com (RVPH) - Company Buyout Price|Enterprise Value MTVA|Enterprise Value NeurAxis Inc. (NRXS)|Total Company Value Helius Medical Technologies HSDT|PASG: Business Value|NEUP: Real Price to Acquire Entire Company|NERV: Total Company Value|Athira Pharma (ATHA) - Total Company Value|ADXN - Company Buyout Price|Total Company Value Alzamend Neuro Inc.|Business Value CYCN (Cyclerion)|Enterprise Value PTIX|KTTA - Total Enterprise Value|Cortigent - Real Price to Acquire Entire Company|Enterprise Value Avenue Therapeutics Inc. ATXI|BCLI - Total Company Value|Value Adjusted for Debt and Cash CARA (Cara Therapeutics Inc)|Chromocell Therapeutics (CHRO) - Total Company Value|Total Enterprise Value Eliem Therapeutics Inc. (ELYM)|ITCI (Intra-Cellular Therapies Inc.) - Enterprise Value|Enterprise Value Longboard Pharmaceuticals Inc|Total Company Value Marinus (MRNS)|NKGen Biotech Corp - Business Value|Total Company Value NeuroBo Pharmaceuticals NRBO|SAGE: Business Value|SNPX - Total Company Value|Total Enterprise Value Trevena Inc.|VIGL (vigilneuro.com) - Real Price to Acquire Entire Company|WENA (anewmeds.com) - Total Company Value|CERE (Cerevel Therapeutics) - Enterprise Value